A 59-year-old woman was diagnosed with essential thrombocythemia in 1988 and had been treated with hydroxyurea, mitobronitol, busulfan, and ranimustine, in that order. Hepatosplenomegaly, low-grade fever, and body weight loss manifested, and a few blasts were noted in the peripheral blood studied in March 2002. A biopsied specimen of the bone marrow showed myelofibrosis but not a leukemia in August 2004. An abnormal karyotype with der(1;13) appeared for the first time. She was treated with low-dose prednisolone. In January 2005, she experienced left hip joint pain, and magnetic resonance scanning showed a tumoral lesion in the femoral head. Histological diagnosis of the biopsied mass revealed that it was a granulocytic sarcoma, and radiotherapy was performed. In April 2005, bone scintigraphy showed multiple lesions. She became febrile and red blood cell transfusion-dependent with hepatosplenomegaly and a small number of circulating blasts. Intravenous cytarabine (low dose) and etoposide relieved the fever and hepatosplenomegaly; however, she developed a pathologic fracture of the right humerus.An additional karyotypic abnormality (7q22 deletion) was noted. She subsequently died of infection. Granulocytic sarcoma is very rare in essential thrombocythemia, and this patient may be the first reported case of essential thrombocythemia that developed multiple lesions and a pathologic fracture without transformation to overt leukemia.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Cristolini A, Mazzucconi MG, Ferrari A, et al. Essential thrombo-cythemia: a retrospective study on the clinical course of 100 patients. Hematologica. 1990;75:537–540.
Fenaux P, Simon M, Caulier MT, et al. Clinical course of essential thrombocythemia in 147 cases. Cancer. 1990;66:549–556.
Hehlman R, Jahn M, Bauman B, et al. Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer. 1988;61:2487–2496.
Hattori A, Nagayama R, Kishi K, et al. Primary thrombocythemia in Japan: a survey of 225 patients. Leuk Lymphoma. 1990;4:177–186.
Shibata K, Shimamoto Y, Suga K, Sano M, Matsuzaki M, Yamaguchi M. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation—a brief review of recent literature. Acta Haematol. 1994;91:84–88.
Burns A. Observations of surgical anatomy. In: Head and Neck. London, England: Royce; 1811:364.
Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, Section III, Fascicle 8. Washington, DC: Armed Forces Institute of Pathology; 1967:241–247.
Byrd BC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13:1800–1816.
Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426–1437.
Au WY, Shek TW, Ma SK, et al. Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia. J Clin Oncol. 2000;18:3996–3997.
Grande M. Central nervous system granulocytic sarcoma in a patient with essential thrombocythemia. Am J Hematol. 1996;51:64–67.
Hamadani M, Tfayli A, Sethi S, Awab A, Hamdani N. Granulocytic sarcoma manifesting as multiple skeletal lesions. Am J Med Sci. 2005;330:139–43.
Whang-Peng BJ, Young RC, Lee EC, et al. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 1988;71:403–414.
Le Beau MM, Albain KS, Larsen RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndrome and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes nos. 5 and 7. J Clin Oncol. 1986;4:325–345.
Sterkers Y, Predhomme C, Laü J-L, et al. Acute leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. 1998;91:616–622.
Finazzi G, Barbui T. Efficacy and safety of hydroxyurea in patients with essential thrombocythemia. Pathol Biol. 2001;49:167–169.
Hsiao HH, Ito Y, Sashida G, et al. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia. Leuk Res. 2005;29:1247–1252.
About this article
Cite this article
Tanaka, Y., Nagai, Y., Mori, M. et al. Multiple Granulocytic Sarcomas in Essential Thrombocythemia. Int J Hematol 84, 413–416 (2006). https://doi.org/10.1532/IJH97.06081
- Granulocytic sarcoma
- Essential thrombocythemia
- Pathologic fracture
- 7q22 Deletion
- Alkylating agent